alea-institute/kl3m-data-sample-004-shuffled huggingface dataset:
<PAGE>

                                                                    Exhibit 32.1

                    CERTIFICATION OF CHIEF EXECUTIVE OFFICER
                       PURSUANT TO 18 U.S.C. SECTION 1350,
                             AS ADOPTED PURSUANT TO
                  SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002

      In connection with the Quarterly Report of Metretek Technologies, Inc.
(the "Company") on Form 10-Q for the quarterly period ended March 31, 2005 as
filed with the Securities and Exchange Commission on the date hereof (the
"Report"), I, W. Phillip Marcum, President and Chief Executive Officer of the
Company, hereby certify, pursuant to 18 U.S.C. Section 1350, as adopted pursuant
to Section 906 of the Sarbanes-Oxley Act of 2002, that:

      1.    The Report fully complies with the requirements of Section 13(a) or
            15(d) of the Securities Exchange Act of 1934, as amended; and

      2.    The information contained in the Report fairly presents, in all
            material respects, the financial condition and result of operations
            of the Company.

Date: May 16, 2005                      /s/ W. Phillip Marcum
                                        ----------------------------------------
                                           W. Phillip Marcum
                                           President and Chief Executive Officer

A signed original of this written statement required by Section 906 has been
provided to the Company and will be retained by the Company and furnished to the
Securities and Exchange Commission or its staff upon request.
**UNITEDSTATES**

**SECURITIESAND EXCHANGE COMMISSION**

**Washington,D.C. 20549**

**FORM10-K**

                                                       (Mark One)

                                                       [X]

**                                                     Annual Report Pursuant to Section 13 or 15(d) of the Securities Exchange Act of1934**

                                          For the year ended December 31, 2003

or

                                                       [   ]

**                                                     Annual Report Pursuant to Section 13 or 15(d) of the Securities Exchange Act of1934**

                                                        For the transition period from ___________________ to ____________________

                                        Commission File Number 0-27958

**                          FLANDERS CORPORATION**

                                     (Exact name of registrant as specified in its charter)

| North        Carolina

(State        or other jurisdiction of incorporation or organization)       | 13-3368271

(IRS        Employer ID Number) |
|----------------------------------------------------------------------------------------------------|---------------------------------------------|
| 2399        26th Avenue North, St. Petersburg, FL

(Address        of principal executive offices) | 33734

(Zip        Code)                    |

                                                     Registrants telephone number, including area code:  (727) 822-4411

                                                     Securities registered pursuant to Section 12(b) of the Act:  None

                                                     Securities registered pursuant to Section 12(g) of the Act:

Title of eachclass

Common Stock, $.001 per share par value

> 
Indicate by check mark whether the  registrant: (1) has filed all reports required to be filed by Section 13 or  15(d) of the Securities Exchange Act of 1934 during the preceding 12 months  (or for such shorter period that the registrant was required to file such  reports), and (2) has been subject to such filing requirements for the past 90  days.

YES_X__

NO      

 

> 
Indicate by check mark if  disclosure of delinquent filers pursuant to Item 405 of Regulation S-K is not  contained herein, and will not be contained, to the best of registrants  knowledge, in definitive proxy or information statements incorporated by  reference in Part III of this Form 10-K or any amendment to this Form 10-K.

YES___

NO   X 

As of March 26, 2003,the aggregate market value of the voting stock held by non-affiliates of theregistrant was approximately

$26.3 million.

 

Indicate by check markwhether the registrant is an accelerated filer (as defined in Rule 12b-2 of theExchange Act).

YES___

NO   X 

 

As of February 23, 2004, the number of sharesoutstanding of the registrants common stock was 26,151,846 shares.

 

Documents incorporatedinto this report on Form 10-K by reference: None.
Exhibit 31.2

CERTIFICATION OF THE CHIEF FINANCIAL OFFICER

I, Kenneth Y. Tanji, certify that:

1. I have reviewed this Quarterly Report on Form 10-Q of Prudential Annuities Life Assurance Corporation;

2. Based on my knowledge, this Quarterly Report does not contain any untrue statement of a material fact or omit to state a material fact necessary to
make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report;

3. Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the
registrant as of, and for, the periods presented in this report;

4. The registrants other certifying officer(s) and I are
responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) for the registrant and we have:

a) Designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the
registrant is made known to us by others within such entity, particularly during the period in which this report is being prepared;

b) Evaluated the effectiveness of the registrants disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered
by this report based on such evaluation; and

c) Disclosed in this report any change in the registrants internal
control over financial reporting that occurred during the registrants most recent fiscal quarter (the registrants fourth fiscal quarter in the case of an annual report) that has materially affected, or is reasonably likely to materially
affect, the registrants internal control over financial reporting; and

5. The registrants other certifying officer(s) and I
have disclosed, based on our most recent evaluation of internal control over financial reporting, to the registrants auditors and the audit committee of the registrants board of directors (or persons performing the equivalent functions):

a) All significant deficiencies and material weaknesses in the design or operation of internal control over financial
reporting which are reasonably likely to adversely affect the registrants ability to record, process, summarize and report financial information; and

b) Any fraud, whether or not material, that involves management or other employees who have a significant role in the registrants internal control over financial reporting.

Date: May 15, 2009



/s/ Kenneth Y. TanjiKenneth Y. TanjiExecutive Vice President and Chief Financial Officer
#### People v Pines,

No. 90960;

Court of Appeals No. 112573.
### IN THE UNITED STATES COURT OF APPEALS FOR THE FIFTH CIRCUIT

No. 16

- 40869 Summary Calendar

UNITED STATES OF AMERICA,

Plaintiff

–

Appellee ,

v.

RILEY RENE VALLEJO , Defendant

– Appellant

.

Appeal from the United States District Court for the Southern District of Texas USDC No. 1:15

- CR

- 735

- 2

Before REAVLEY, OWEN, and ELROD, Circuit Judges. PER CURIAM: *
The attorney appointed to represent Riley Rene Vallejo has moved for
leave to withdraw and has filed a brief in accordance with Anders v. California , 386 U.S. 738 (1967), and United States v. Flores , 632 F.3d 229 (5th Cir. 2011). Vallejo has filed a response. The record is not sufficiently d eveloped to allow us to make a fair evaluation of Vallejo ’s claim of ine ffective assistance related
to his mental health issues ; we ther efore decline to consider the claim without

* Pursuant to 5 TH C IR

. R. 47.5 , the court has determined that this opinion should not be published and is not precedent except under the limited circumstances set forth in 5 TH C IR

. R. 47.5.4. United States Court of Appeals Fifth Circuit 

### FILED June 21, 2017 Lyle W. Cayce Clerk Case: 16-40869 Document: 00514043275 Page: 1 Date Filed: 06/21/2017No. 16

- 40869

2 prejudice to collateral review. See United States v. Isgar , 739 F.3d 829, 841 (5th Cir. 2014 )

. We have reviewed counsel’s brief and the relevant portions of the record reflected therein, as well as Vallejo ’s response. We concur with counsel’s

assess ment that the appeal presents no nonfrivolous issue for appellate review ; we further determine that Vallejo’s remaining claims of ineffective assistance of counsel present no nonfrivolous issues for appeal . Accordingly, the motion for leave to withdraw is GRANTED, counsel is excused from further responsibilities herein, and the APPEAL IS DISMISSED. See 5 TH C IR

. R . 42.2. Case: 16-40869 Document: 00514043275 Page: 2 Date Filed: 06/21/2017
<PAGE>   1
                                                                     EXHIBIT 11

                LIVING CENTERS OF AMERICA, INC. AND SUBSIDIARIES
                       COMPUTATION OF PER SHARE EARNINGS
                    (in thousands, except per share amounts)
                                  (unaudited)

<TABLE>
<CAPTION>

                                                     Three Months             Six Months
                                                    Ended March 31,         Ended March 31,
                                                  -------------------     -------------------
                                                   1997        1996        1997        1996

ASSUMING FULL DILUTION (a)

<S>                                               <C>         <C>         <C>         <C>    
Net Income                                        $12,214     $12,412     $22,539     $23,311
                                                  =======     =======     =======     =======


Applicable Common Shares:

    Weighted average shares outstanding
        during the period                          19,539      20,235      19,521      20,221

    Weighted average shares issuable upon
        exercise of common stock options
        using the treasury stock method               287         271         287         271

    Weighted average shares issuable
        upon exercise of warrants using
        the treasury stock method                    --            15        --            15

                                                  -------     -------     -------     -------

    Total shares                                   19,826      20,521      19,808      20,507
                                                  =======     =======     =======     =======




Earnings per share (fully diluted)                $  0.62     $  0.60     $  1.14     $  1.14
                                                  =======     =======     =======     =======
</TABLE>


(a)    This calculation is submitted in accordance with Regulation S-K, item
       601 (b) (11) although not required by footnote 2 to paragraph 14 of APB
       Opinion No. 15 because it results in less than 3% dilution.
<TABLE> <S> <C>


<ARTICLE>                     5
<LEGEND>
The  schedule  contains  summary  financial   information   extracted  from  the
consolidated  balance  sheets  and  consolidated  statements  of  income  and is
qualified in its entirety by reference to such financial statements.
</LEGEND>

       
<S>                                         <C>
<PERIOD-TYPE>                                3-MOS     
<FISCAL-YEAR-END>                            DEC-31-1998  
<PERIOD-END>                                 MAR-31-1998
<CASH>                                         2,264,707
<SECURITIES>                                           0
<RECEIVABLES>                                    181,400 
<ALLOWANCES>                                           0
<INVENTORY>                                      432,116
<CURRENT-ASSETS>                                       0 
<PP&E>                                        16,001,233 
<DEPRECIATION>                                         0
<TOTAL-ASSETS>                                22,480,312 
<CURRENT-LIABILITIES>                                  0
<BONDS>                                                0
<PREFERRED-MANDATORY>                                  0
<PREFERRED>                                            0
<COMMON>                                               0
<OTHER-SE>                                    11,679,002 
<TOTAL-LIABILITY-AND-EQUITY>                  22,480,312 
<SALES>                                          179,867
<TOTAL-REVENUES>                               2,116,487
<CGS>                                                  0
<TOTAL-COSTS>                                  1,753,879
<OTHER-EXPENSES>                                  70,781
<LOSS-PROVISION>                                  25,000
<INTEREST-EXPENSE>                               174,513
<INCOME-PRETAX>                                  362,608
<INCOME-TAX>                                           0
<INCOME-CONTINUING>                              362,608 
<DISCONTINUED>                                         0
<EXTRAORDINARY>                                        0
<CHANGES>                                              0
<NET-INCOME>                                     362,608
<EPS-PRIMARY>                                       2.54
<EPS-DILUTED>                                       2.54
        


</TABLE>
<PAGE>


                                   EXHIBIT 11

                           DURA PHARMACEUTICALS, INC.
               STATEMENTS RE COMPUTATIONS OF NET INCOME PER SHARE
                     IN THOUSANDS, EXCEPT PER SHARE AMOUNTS
                                   (UNAUDITED)

<TABLE>
<CAPTION>

                                                                 THREE MONTHS ENDED
                                                                      MARCH 31,
                                                              2000                 1999
                                                         -------------------------------
<S>                                                      <C>                   <C>
NET INCOME PER SHARE - BASIC

Net income                                               $  12,458             $  7,766
                                                         =========             ========

Weighted average number of common shares:
      Common stock                                          44,335               44,100
                                                         =========             ========

Net income per share                                     $    0.28             $   0.18
                                                         =========             ========

NET INCOME PER SHARE - DILUTED

Net income                                               $  12,458             $  7,766
                                                         =========             ========

Weighted average number of common and
   common equivalent shares assuming
   issuance of all dilutive contingent shares:
      Common stock                                          44,335               44,100
      Stock options                                          1,259                  910
      Warrants                                                 564                  676
                                                         ---------             --------
         Total                                              46,158               45,686
                                                         =========             ========

Net income per share                                     $    0.27             $   0.17
                                                         =========             ========
</TABLE>
<TABLE> <S> <C>

<ARTICLE>  5
<MULTIPLIER>  1000
       
<CAPTION>                                     RESTATED
<S>                             <C>           <C>
<PERIOD-TYPE>                   9-MOS         9-MOS
<FISCAL-YEAR-END>               DEC-31-1998   DEC-31-1997
<PERIOD-START>                  JAN-01-1998   JAN-01-1997
<PERIOD-END>                    SEP-30-1998   SEP-30-1997
<CASH>                              0          1564
<SECURITIES>                        0             0
<RECEIVABLES>                   43307         35595
<ALLOWANCES>                     2191          3418
<INVENTORY>                         0             0
<CURRENT-ASSETS>                41851         42171
<PP&E>                           8422         10045
<DEPRECIATION>                   4831          7761
<TOTAL-ASSETS>                  47111         48376
<CURRENT-LIABILITIES>           29265         26944
<BONDS>                             0             0
<COMMON>                          100           100
<PREFERRED-MANDATORY>               0             0
<PREFERRED>                         0             0
<OTHER-SE>                      15663         20629
<TOTAL-LIABILITY-AND-EQUITY>    47111         48376
<SALES>                         83105         69650
<TOTAL-REVENUES>                83105         69650
<CGS>                           65412         58793
<TOTAL-COSTS>                   65412         58793
<OTHER-EXPENSES>                12149          7132
<LOSS-PROVISION>                    0             0
<INTEREST-EXPENSE>                854          1329
<INCOME-PRETAX>                  4690          2396
<INCOME-TAX>                     1760           899
<INCOME-CONTINUING>              2930          1497
<DISCONTINUED>                  (2482)         1526
<EXTRAORDINARY>                     0             0
<CHANGES>                           0             0
<NET-INCOME>                      448          3023
<EPS-PRIMARY>                     .05           .32
<EPS-DILUTED>                     .05           .32

        

</TABLE>
Document Headings

                    Document headings vary by document type but may contain                    the following:                  
                -                       the agency or agencies that issued and signed a document                    
                -                       the number of the CFR title and the number of each part                      the document amends, proposes to amend, or is directly                      related to                    
                -                       the agency docket number / agency internal file number                    
                -                       the RIN which identifies each regulatory action listed in                      the Unified Agenda of Federal Regulatory and Deregulatory                      Actions                    

                    See the                                          Document Drafting Handbook                                        for more details.                  

###### Department of State

          - [Public Notice: 11638]

# SUMMARY:

                        Notice is hereby given of the following determinations: I hereby determine that a certain object, entitled “Hercules and Omphale” by Artemisia Gentileschi, being imported from abroad pursuant to an agreement with its foreign owner or custodian for temporary conservation, scientific research, and exhibition or display at The J. Paul Getty Museum at the Getty Center, Los Angeles, California, and at possible additional exhibitions or venues yet to be determined, is of cultural significance, and, further, that its temporary conservation, scientific research, and exhibition or display within the United States as aforementioned are in the national interest. I have ordered that Public Notice of these determinations be published in the                         **Federal Register**                        .                    

# FOR FURTHER INFORMATION CONTACT:

                        Chi D. Tran, Program Administrator, Office of the Legal Adviser, U.S. Department of State (telephone: 202-632-6471; email:                         *section2459@state.gov*). The mailing address is U.S. Department of State, L/PD, 2200 C Street NW (SA-5), Suite 5H03, Washington, DC 20522-0505.                    

# SUPPLEMENTARY INFORMATION:

                    The foregoing determinations were made pursuant to the authority vested in me by the Act of October 19, 1965 (79 Stat. 985; 22 U.S.C. 2459), E.O. 12047 of March 27, 1978, the Foreign Affairs Reform and Restructuring Act of 1998 (112 Stat. 2681,                     *et seq.;*22 U.S.C. 6501 note,                     *et seq.*), Delegation of Authority No. 234 of October 1, 1999, Delegation of Authority No. 236-3 of August 28, 2000, and Delegation of Authority No. 523 of December 22, 2021.                

Stacy E. White,

Deputy Assistant Secretary for Professional and Cultural Exchanges, Bureau of Educational and Cultural Affairs, Department of State.

[FR Doc. 2022-01862 Filed 1-28-22; 8:45 am]

BILLING CODE 4710-05-P
<PAGE>

                                  EXHIBIT 99.2

                               18 U.S.C. ss.1350,
AS ADOPTED PURSUANT TO
SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002

Certification of Chief Financial Officer of Aethlon Medical, Inc., Inc.

In connection with the Quarterly Report of Aethlon Medical, Inc. (the "Company")
on Form 10-QSB for the period ended December 31, 2002 as filed with the
Securities and Exchange Commission on the date hereof (the "Report"), I, Edward
Hall, Chief Financial Officer of the Company, certify, pursuant to 18 U.S.C.
ss.1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002
that:

1. The Report fully complies with the requirements of Section 13(a) or 15(d) of
the Securities Exchange Act of 1934; and

2. The information contained in the Report fairly presents, in all material
respects, the financial condition and results of operations of the Company.

                         /S/ EDWARD C. HALL
                         ------------------
                         EDWARD C. HALL
                         CHIEF FINANCIAL OFFICER
                         FEBRUARY 19, 2003